معرفی
Markku Varjosalo is a Research Director at the Institute of Biotechnology, University of Helsinki, and a supervisor in the Doctoral Programmes in Biomedicine, Drug Research, and Integrative Life Science. His research focuses on biochemistry, molecular biology, and proteomics, with particular emphasis on gene fusions in cancer, immune response mechanisms, and protein interaction networks.
- Current projects include funding from Sigrid Jusélius Foundation (2025-2026) and Finnish Science Society (2025-2026)
- Active in Biocenter Finland infrastructure projects (2024-2025, 2024-2028)
His recent publications highlight interdisciplinary work in proteomics, disease mechanisms, and systems biology approaches. He participates in organizing academic events like iCAN retreat 2024 and contributes to research infrastructure coordination through Instruct-ERIC. Funded by major Finnish research councils and foundations, his work spans cancer biology, cardiovascular genetics, and immunology.
